Home ENGLISH Page 3

ENGLISH

Latest

Rare disease startup Therachon to absorb GLyPharma and its SBS candidate

admin -
0

Affimed tumbles as it puts brakes on T cell engager

admin -
0

Novartis cozies up to Silicon Valley with new lab

admin -
0

Sinntaxis bags option on ex-AstraZeneca mGluR5 antagonist

admin -
0

Spark plans 2019 clinical trial of gene therapy for Pompe disease after positive mouse...

admin -
0

Akcea sets off after Alnylam’s hATTR therapy in U.S., but with a handicap

admin -
0

Scientists use CRISPR to treat genetic liver diseases in neonatal and adult mice

admin -
0

Phase 3 rare disease flop leaves Diurnal reeling

admin -
0

GlaxoSmithKline helps immunometabolism startup Sitryx to $30M round

admin -
0

Xencor’s lead lupus antibody misses phase 2 endpoint

admin -
0

Orchard files for $173M IPO to run pivotal gene therapy trials

admin -
0

Arena preparing for trials of first-in-class heart failure drug

admin -
0

DDF 2018: How do you fix the glut of immunotherapy combo trials?

admin -
0

European biotech funding on track for record year

admin -
0

Chutes & Ladders—Pfizer CEO Ian Read hands reins to COO Albert Bourla

admin -
0

Nimbus moves up CFO Keiper to CEO spot

admin -
0

Private equity giant Blackstone buys Clarus in biopharma push

admin -
0

Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B...

admin -
0
1234...1,459Page 3 of 1,459
©